We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PARA
151
DELISTED
Paramount Global Class B
PARA
$616K 0.16%
10,624
+1,423
+15% +$89.9K
SJM icon
152
J.M. Smucker
SJM
$12.6B
$612K 0.16%
5,837
-1,377
-19% -$157K
MTB icon
153
M&T Bank
MTB
$36B
$611K 0.16%
3,797
+481
+15% +$75.6K
WHG icon
154
Westwood Holdings Group
WHG
$183M
$611K 0.16%
9,084
+968
+12% +$57.9K
IPG
155
DELISTED
Interpublic Group of Companies
IPG
$610K 0.16%
29,326
+3,974
+16% +$86.4K
WINA icon
156
Winmark
WINA
$1.21B
$606K 0.16%
4,601
+400
+10% +$52.4K
MXIM
157
DELISTED
Maxim Integrated Products
MXIM
$606K 0.16%
12,694
+176
+1% +$8.07K
INBK icon
158
First Internet Bancorp
INBK
$230M
$596K 0.16%
18,466
+1,324
+8% +$40.3K
MAN icon
159
ManpowerGroup
MAN
$2.4B
$595K 0.16%
5,048
+523
+12% +$58.5K
NUVA
160
DELISTED
NuVasive, Inc.
NUVA
$594K 0.16%
+10,714
New +$709K
NSIT icon
161
Insight Enterprises
NSIT
$3.57B
$590K 0.16%
12,842
+2,082
+19% +$85.7K
INTU icon
162
Intuit
INTU
$80.4B
$589K 0.16%
4,144
+375
+10% +$51.8K
NLSN
163
DELISTED
Nielsen Holdings plc
NLSN
$576K 0.15%
13,891
+1,236
+10% +$49.4K
RF icon
164
Regions Financial
RF
$26.2B
$574K 0.15%
37,717
+5,198
+16% +$74.7K
MOBL
165
DELISTED
MobileIron, Inc.
MOBL
$572K 0.15%
+154,545
New +$693K
MRK icon
166
Merck
MRK
$324B
$565K 0.15%
9,251
-922
-9% -$55.9K
DFS
167
DELISTED
Discover Financial Services
DFS
$559K 0.15%
8,676
+615
+8% +$37.3K
NATH icon
168
Nathan's Famous
NATH
$403M
$558K 0.15%
7,550
+942
+14% +$60.1K
FLXS icon
169
Flexsteel Industries
FLXS
$309M
$543K 0.14%
10,708
+1,250
+13% +$63.7K
KINS icon
170
Kingstone Companies
KINS
$288M
$541K 0.14%
33,197
+4,096
+14% +$63.3K
REIS
171
DELISTED
Reis, Inc.
REIS
$539K 0.14%
29,917
+75
+0.3% +$1.41K
JCI icon
172
Johnson Controls International
JCI
$87B
$529K 0.14%
13,124
+1,714
+15% +$69.3K
CAH icon
173
Cardinal Health
CAH
$53.3B
$522K 0.14%
7,799
+1,391
+22% +$98.3K
DDS icon
174
Dillards
DDS
$8.87B
$522K 0.14%
+9,311
New +$573K
OPB
175
DELISTED
Opus Bank Common Stock
OPB
$515K 0.14%
21,443
+740
+4% +$17.1K
5 6
7
8 9

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.